KRISTEN HOOD: Open Payments
NPI 1518726538 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$443 in 13 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $1,003 · 2025 $443
Food & beverage: $269Education: $174
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 3 | $137 |
| SEAGEN INC. | 1 | $95 |
| Novartis Pharmaceuticals Corporation | 3 | $84 |
| Rigel Pharmaceuticals, Inc. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| BeiGene USA, Inc. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Gilead Sciences, Inc. | 1 | $19 |
Products named: Enhertu, SCEMBLIX, TAVALISSE, OJJAARA, ORGOVYX, TEVIMBRA, Nubeqa, Trodelvy.
Industry payments across GA — which companies pay providers there.
